Funding Rounds
BioVersys

BioVersys Series B (2020, $20M)

BioVersys

Novel antiobiotic researcher to fight antimicrobial resistance.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $20.90M

Raised Date: 2020-01-01